Biological response modifiers (BRMS) are drugs that target inflammatory pathways in rheumatoid arthritis (RA) and represent a relatively new approach to the treatment of RA...

Rheumatoid arthritis is the most common inflammatory form of arthritis It affects more than 2 million Americans...

Rheumatoid arthritis (RA) is a chronic, autoimmune, systemic, inflammatory disorder characterized by joint inflammation and joint destruction...

A recent study has shown that the use of a combination of a tumor necrosis factor (TNF) inhibitor along with methotrexate therapy in people with rheumatoid arthritis (RA) was associated with a reduction in heart attack risk of 80 percent compared with patients using methotrexate alone, according to research presented recently at the American College of Rheumatology Annual Scientific Meeting in Boston, Mass...

Since the early 1980’s methotrexate has assumed the position of “gold standard” as a disease modifying anti-rheumatic drug (DMARD) for rheumatoid arthritis (RA)...

One drug that is often used in the early treatment of rheumatoid arthritis is prednisone Prednisone is a glucocorticoid...

Up until the mid 1990’s the best we, as rheumatologists could do with patients with rheumatoid arthritis (RA), was to relieve their pain, suppress their disease a bit, and maybe slow it down some...

Methotrexate is the most commonly used disease-modifying anti-rheumatic drug (DMARD) used in the treatment of rheumatoid arthritis (RA)...

Research studies have demonstrated that there is a narrow window of opportunity that exists between the times that a patient develops rheumatoid arthritis (RA) and when the disease begins to cause destructive, irreversible changes in the joints...

Methrotrexate is a medication that is given to patients to help treat the arthritis that they have If you are given this type of prescription, you are likely to get an injection of it weekly, or sometimes it is given orally...